期刊文献+

系统性硬化病合并关节炎的临床分析 被引量:1

The prevalence and clinical significance of arthritis in patients with systemic sclerosis
原文传递
导出
摘要 目的 探讨系统性硬化病(SSc)合并关节炎的临床特征.方法 横断面分析SSc合并关节炎患者的临床表现和实验室检查资料.结果 248例SSc患者发病年龄(37.1±13.7)岁,102例合并关节炎,发病率为41.1%.SSc合并关节炎者关节痛(95.1%)、肌无力(38.2%)、活动后气短(60.8%)及间质性肺疾病(64.7%)的发生率高于SSc未合并关节炎者(15.1%、24.7%、45.2%、49.3%),差异有统计学意义(P值均<0.05).SSc合并关节炎者C反应蛋白升高者比例(61.4%)、抗Sm抗体阳性率(11.4%)、抗CCP抗体阳性率(28.1%)高于SSc未合并关节炎者(43.9%、2.5%、2/16;P值均=0.01).两者间在Rodnan皮肤硬皮评分、指端溃疡、肺动脉高压和6分钟步行距离试验比较差异无统计学意义(P值均>0.05).结论 SSc合并关节炎的发生率高,且可能与疾病炎症程度和继发间质性肺疾病有相关性,临床医生应重视SSc合并关节炎的早期识别. Objective To explore the prevalence and independent influencing factors of arthritis in Chinese patients with systemic sclerosis(SSc).Methods A total of 248 SSc patients were enrolled in this prospective cross-sectional study in Peking Union Medical College Hospital.Demographic,clinical and laboratory data were compared in arthritis group and non-arthritis group.Results Of 248 Chinese SSc patients,mean age of onset was (37.1 ± 13.7) years old and disease duration was (7.4 ± 5.2) years.Overall prevalence of arthritis was 41.1% (102/248).The presence of arthralgia(95.1% vs 15.1%),muscle weakness(38.2% vs 24.7%),short of breath (60.8% vs 45.2%),and intestinal lung disease (64.7% vs 49.3%) occurred more frequently in patients with arthritis than those without arthritis (P 〈0.05).The elevation of C reactive protein,anti-Sm and anti-cyclic citrullinated peptide were more common in arthritis group than in non-arthritis group(61.4% vs 43.9%,11.4% vs 2.5% and 28.1% vs 2/16,respectively).There were no obvious differences in the Rodnan score,digital ulcers,pulmonary arterial hypertension,and six-minute walk test between two groups(P 〉 0.05).Conclusion This study reveals the significant prevalence of arthritis in a large cohort of SSc patients in China.Compared to non-arthritis patients,the SSc patients with arthritis have a more severe inflammation reaction and a higher rate of intestinal lung disease.
出处 《中华内科杂志》 CAS CSCD 北大核心 2014年第6期460-463,共4页 Chinese Journal of Internal Medicine
基金 欧洲抗风湿病联盟硬皮病试验研究队列研究 国家自然科学基金(81102268) 中华医学会临床医学科研专项资金项目(12040740374)
关键词 硬化病 系统性 关节炎 间质性肺疾病 Scleroderma,systemic Arthritis Lung diseases,intestinal
  • 相关文献

参考文献14

  • 1Baron M,Lee P,Keystone EC.The articular manifestations of progressive systemic sclerosis (scleroderma)[J].Ann Rheum Dis,1982,41:147-152.
  • 2TUFFANELLI DL,WINKELMANN RK.Systemic scleroderma,A clinical study of 727 cases[J].Arch Dermatol,1961,84:359-371.
  • 3Preliminary criteria for the classification of systemic sclerosis (scleroderma).Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee[J].Arthritis Rheum,1980,23:581-590.
  • 4Xu D,Li MT,Hou Y,et al.Clinical characteristics of systemic sclerosis patients with digital ulcers in China[J].Clin Exp Rheumatol,2013,31 (2 Suppl 76):46-49.
  • 5徐东,李梦涛,侯勇,王迁,白依娜,宋宁,曾小峰,曾勇.系统性硬化病患者临床表现分析:来自中国欧洲抗风湿病联盟硬皮病试验研究组数据库资料[J].中华风湿病学杂志,2011,15(7):455-459. 被引量:20
  • 6Liu X,Li M,Xu D,et al.Prevalence and clinical importance of gastroesophageal reflux in Chinese patients with systemic sclerosis[J].Clin Exp Rheumatol,2012,30(2 Suppl 71):S60-66.
  • 7徐东,李梦涛,侯勇,王迁,胡朝军,曾小峰.系统性硬化病患者指溃疡的关联因素分析:来自中国欧洲抗风湿病联盟硬皮病试验研究组数据库的资料[J].中华风湿病学杂志,2012,16(2):87-90. 被引量:6
  • 8Cuomo G,Zappia M,Abignano G,et al.Ultrasonographic features of the hand and wrist in systemic sclerosis[J].Rheumatology (Oxford),2009,48:1414-1417.
  • 9Avouac J,Walker U,Tyndall A,et al.Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis:results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database[J].J Rheumatol,2010,37:1488-1501.
  • 10Jinnin M,Ihn H,Yamane K,et al.Clinical features of patients with systemic sclerosis accompanied by rheumatoid arthritis[J].Clin Exp Rheumatol,2003,21:91-94.

二级参考文献17

  • 1Low AHL, Johnson SR, Lee P. Ethnic Influence on diseasemanifestations and autoantibodies in Chinese-descent patients with systemic sclerosis. J Rheumatol, 2009, 36: 787-793.
  • 2Chifflot H, Fautzi B, Sorder C, et al. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum, 2008, 37: 223-235.
  • 3Armando G, Enrico VA, Thomas K.Scleroderma. N Engl J bled, 2009, 360: 1989-2003.
  • 4Walker UA, Tyndall A, Czirj6k L, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research Group database. Ann Rheum Dis, 2007, 66: 754-763.
  • 5Allanore Y, Meune C, Vonk MC, et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research Group (EUSTAR) database of systemic sclerosis patients. Ann Rheum Dis, 2010, 69: 218- 221.
  • 6Hegedus I, Czirjak L. Left ventrieular wall motion abnormalities in 80 patients with systemic sclerosis. Clin Rheumatol, 1995, 14: 161-164.
  • 7Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum, 2000, 43: 2437-2444.
  • 8Kahan A, Allanore Y. Primary myocardial involvement in systemic sclerosis. Rheumatology, 2006, 45 : 14-17.
  • 9Ariane H. Diagnosis and management of scleroderma peripheral vascular disease. Rheum Dis Clin Nor Am, 2008, 34: 89-114.
  • 10Newman AB, Siscovick DS, Manolio TA, et al. Ankle-armindex as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CI-IS) Collaborative Research Group. Circulation, 1993, 88: 837-845.

共引文献22

同被引文献12

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部